Description
SWOT ANALYSIS OF BOSTON SCIENTIFIC
Boston Scientific
Parent Company
Boston Scientific Corporation
Category
Healthcare
Sector
Medical devices
Tagline/ Slogan
Advancing science for life
A team with the passion, drive, and confidence to believe our innovative medical solutions can transform lives and improve the health USP of patients around the world.
STP
Segment
Global developer and marketer of interventional medical devices
Devices used in cardiac rhythm management, cardiac and vascular surgery, electrophysiology, tumor reduction, cancer treatments, Target Group hearing reduction; and pain management
We are a leading innovator of medical solutions that improve the health Positioning of patients around the world.
SWOT Analysis
1. Well known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries 2. Strong top management reflected by increased share prices when the new CEO stepped in 3. Acquisition of Guidant gives the company immense depth in heart devices market 4. Product marketing done in 100 countries through its direct sales force – which is very active in 40 countries Strength 5.Strong brand equity with loyal customers
1.Competitive nature of the industry with immense focus on technological advancements and research capabilities 2.Negative publicity due to involvement in controversy regarding illegal Weakness payment to US Army doctor to use their devices
1.Acquisitions of competitors similar to Guidant in 2006 2.Spinoffs from parent company like Navilyst Medical Opportunity 3. Geographical expansion to growth markets
1.FDA rulings and government interventions in healthcare industry 2.Acorss product portfolio, company has to deal with multiple competitors Threats 3.Loss of investor confidence resulting in lesser market capitalization
Competition
1.Abbott Laboratories 2.Johnson & Johnson Competitors 3.Medtronic Inc
doc_939931556.docx
SWOT ANALYSIS OF BOSTON SCIENTIFIC
Boston Scientific
Parent Company
Boston Scientific Corporation
Category
Healthcare
Sector
Medical devices
Tagline/ Slogan
Advancing science for life
A team with the passion, drive, and confidence to believe our innovative medical solutions can transform lives and improve the health USP of patients around the world.
STP
Segment
Global developer and marketer of interventional medical devices
Devices used in cardiac rhythm management, cardiac and vascular surgery, electrophysiology, tumor reduction, cancer treatments, Target Group hearing reduction; and pain management
We are a leading innovator of medical solutions that improve the health Positioning of patients around the world.
SWOT Analysis
1. Well known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries 2. Strong top management reflected by increased share prices when the new CEO stepped in 3. Acquisition of Guidant gives the company immense depth in heart devices market 4. Product marketing done in 100 countries through its direct sales force – which is very active in 40 countries Strength 5.Strong brand equity with loyal customers
1.Competitive nature of the industry with immense focus on technological advancements and research capabilities 2.Negative publicity due to involvement in controversy regarding illegal Weakness payment to US Army doctor to use their devices
1.Acquisitions of competitors similar to Guidant in 2006 2.Spinoffs from parent company like Navilyst Medical Opportunity 3. Geographical expansion to growth markets
1.FDA rulings and government interventions in healthcare industry 2.Acorss product portfolio, company has to deal with multiple competitors Threats 3.Loss of investor confidence resulting in lesser market capitalization
Competition
1.Abbott Laboratories 2.Johnson & Johnson Competitors 3.Medtronic Inc
doc_939931556.docx